Pfizer
PFE
$24.15
Share price
-1.03%
Change (1 day)
-10.49%
Change (1 year)
Categories
Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.
Pfizer (PFE) - Cash on Hand
Cash on Hand as of March 2025 : $17.31 Billion USD
According to Pfizer's latest financial reports the company has $17.31 Billion USD in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Pfizer - Cash on Hand chart (from 1996 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | $20.47 B | 61.36% |
| 2023-12-31 | $12.69 B | -44.18% |
| 2022-12-31 | $22.73 B | -26.83% |
| 2021-12-31 | $31.06 B | 154.18% |
| 2020-12-31 | $12.22 B | 26.72% |
| 2019-12-31 | $9.64 B | -48.78% |
| 2018-12-31 | $18.83 B | -5.8% |
| 2017-12-31 | $19.99 B | 12% |
| 2016-12-31 | $17.85 B | -23.36% |
| 2015-12-31 | $23.29 B | -35.52% |
| 2014-12-31 | $36.12 B | 11.46% |
| 2013-12-31 | $32.40 B | 0.03% |
| 2012-12-31 | $32.39 B | 22.48% |
| 2011-12-31 | $26.45 B | -5.57% |
| 2010-12-31 | $28.01 B | 7.87% |
| 2009-12-31 | $25.96 B | 9.43% |
| 2008-12-31 | $23.73 B | -6.85% |
| 2007-12-31 | $25.47 B | -8.08% |
| 2006-12-31 | $27.71 B | 24.69% |
| 2005-12-31 | $22.22 B | 11.73% |
| 2004-12-31 | $19.89 B | 66.44% |
| 2003-12-31 | $11.95 B | -4.77% |
| 2002-12-31 | $12.55 B | 45.69% |
| 2001-12-31 | $8.61 B | 25.53% |
| 2000-12-31 | $6.86 B | 7.47% |
| 1999-12-31 | $6.38 B | 311.47% |
| 1998-12-31 | $1.55 B | 76.97% |
| 1997-12-31 | $0.87 B | -23.74% |
| 1996-12-31 | $1.15 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Merck MRK | $9.22 B | -46.71% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $38.78 B | 123.96% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $11.78 B | -31.96% | 🇺🇸 USA |
 Eli Lilly LLY | $3.22 B | -81.40% | 🇺🇸 USA |
 Novartis NVS | $7.19 B | -58.44% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | $5.80 B | -66.49% | 🇬🇧 UK |
 Amgen AMGN | $8.81 B | -49.12% | 🇺🇸 USA |
 Abbott Laboratories ABT | $6.84 B | -60.48% | 🇺🇸 USA |
 AstraZeneca AZN | $5.39 B | -68.84% | 🇬🇧 UK |